Page last updated: 2024-10-23

bisindolylmaleimide i and Inflammatory Bowel Diseases

bisindolylmaleimide i has been researched along with Inflammatory Bowel Diseases in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oprins, JC1
Meijer, HP1
Groot, JA1

Other Studies

1 other study available for bisindolylmaleimide i and Inflammatory Bowel Diseases

ArticleYear
Tumor necrosis factor-alpha potentiates ion secretion induced by muscarinic receptor activation in the human intestinal epithelial cell line HT29cl.19A.
    Annals of the New York Academy of Sciences, 2000, Volume: 915

    Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Carbachol; Cholinergic Agonists; HT29 Cells;

2000